“We made this investment because they promised a hundred million doses of the Polio vaccine each year for developing countries, including many in Africa, he said.
A deadline has been defined in the race to develop a vaccine for the coronavirus with precision that has the clarity of an equation if not scientific: the first Monday in November. Donald Trump has repeatedly mentioned during the fall that a vaccine could be approved before the election. The president may prove to be correct, although the product most likely to beat 3 November is Xinxing Guanzhuang Bingdu Miehuo Yimiao (Vero Xibao).
In the meantime, many Chinese citizens have not waited for a complete approval before being injected. The state press reported that hundreds of thousands of people have already been vaccinated by the C.N.B.G. under an emergency use authorization granted by the government. Many government officials and pharmaceutical executives have received the 2-stage vaccination. The AMA knew a few government officials personally, and they told me they had taken the vaccine,” said Yiwu He. He said that more than a hundred Communist Party cadres at the level of juzhang, or director, as well as many executives of C.N.B.G., were vaccinated. – and its parent company, Sinopharm, the biggest pharmaceutical company in China. ” All senior executives in Sinopharm and C.N.B.G. He emphasized that the vaccine – has been vaccinated,” including the C.E.O. Sinopharm, the chairman of the board, each vice-president — anyone,”
For people in the United States and Europe the idea that so many Chinese are vaccinated before the full authorization is shocking. He said that in the West it would be considered anti-science. It is not considered very positively in China but it is viewed as a way for officials and executives to show confidence — and he said that after working with C.N.B.G. He himself has received the vaccine in the past. Although he is currently co-ordinating with investors in hopes of establishing a production facility for a different vaccine in Hong Kong, he said that he would take the C.N.B.G. If it were to be distributed locally, vaccine now would be. But I cannot travel to China without a quarantine of fourteen days.
When I speak to people in the Chinese pharmaceutical and medical industries I always ask, “Are you vaccinated?” Especially in Beijing and Shanghai, it is not unusual for someone in the field to have had access to a vaccine from either C.N.B.G. or CanSino, another Chinese company that is also a Phase III trial provider. Jiang Xilin, a Shanghai native presently studying genomic medicine and statistics at Oxford University, told me that he has arranges for a vaccination when he returns to China during the school holiday. The Biotech investor in Beijing said he would likely wait another month before taking his first dose. He is conservative and he doesn’t travel much so he doesn’t see any reason to rush. Many of his friends and colleagues, however, have already been vaccinated. Some of these friends used to work at Sinopharm, and they have seen people they trust at the company vacufly themselves, he said, explaining that such individuals would have early access to clinical results. The investor did not consider this inappropriate because participation was voluntary. He noted that Gu Fangzhou, the scientist who developed the first live polio vaccine in 1960, had administered it to his infant son before mass trials were carried out. In the United States, Jonas Salk had the same experience with his own polio vaccine. Salk was injected voluntarily at the University of Pittsburgh in 1953, two years before the vaccine was declared safe and effective.
A thirty-four-year old in Beijing told me that he was offered the C.N.B.G. That is because his company involved with Sinopharm in business transactions. This appears to be a uniquely Chinese addition to the Pittsburgh model – from what I can tell, there is nothing on the historical record about Jonas Salk building Guanxi dose by dose. The offer was attractive for a couple of reasons to the young man in Beijing. I examined the results of their Phase II trial online and they looked good, he said in a phone interview. He received his first dose in June and a third in July twenty-eight days later. He experienced no reactions or side effects and he said that the main warnings were to avoid spicy food and alcohol on the night of injections. He signed a waiver whereby he agreed not to publicly talk about the trial. He said: “They told me that it should be effective for six months and perhaps longer. It doesn’t know how long it lasts, but it looks from the early reports that it might be something that one takes once a year.
In China, such participants might contribute to useful data about side effects, but they won’t reveal much about the effectiveness of the vaccine, since the country has been eliminating COVID-19 cases largely since the spring. C.N.B.G. He had to travel far from home to conduct a phase III trial. The company has registered more than fifty thousand subjects in the United Arab Emirates, Peru and other countries in South America and the Middle East, which are currently experiencing outbreaks. Earlier this month, Nawal al-Kaabi, the chief of the U.S.-A.E. COVID-19 Clinical Management Committee, said that none of the thirty-one thousand volunteers who took the Chinese vaccination experienced serious side effects. On September 14 the U.A.E. The vaccine received emergency approval for at risk professions. G.L. C.N.B.G. the first coronavirus vaccine manufacturer to obtain permission for use in a foreign country.
That’s another thing to understand about the Chinese push for a vaccine: This is not Russia. While Russian efforts to quickly speed up a vaccine have been met with widespread scepticism, people in the field take Chinese technology and professionalism seriously. After a series of vaccine scandals in the twenty-eighteens, China pushed stricter regulations and standards for a phase III trial are similar to those in the United States. During the last decade, China joined the International Council for Harmonization, a pharmaceutical – regulatory body with strict requirements. C.N.B.G. is a state-owned company and in recent years has produced nearly eighty percent of China’s vaccines, in his current project receiving almost unlimited government support. It has also received from a history of international cooperation. The Gates Foundation chose C.N.B.G. in the twenty-twentieth century. As a partner in its efforts to eradicate polio in the world. The foundation provided grants and technical support to C.N.B.G. Develop a Polio vaccine production line capable of export at scale. Yiwu He, who worked as a deputy director at Gates Foundation before his current post at the University of Hong Kong told me that he personally escorted Bill Gates on a tour of the C.N.B.G. The facilities — a detail that is certain to delight conspiracy theorists if the Chinese company vouches for the American election even though they lose.
“We made that investment because they promised to produce a hundred million doses of the polio vaccine annually for developing countries, including many in Africa,” he said. She was really happy with the post-symbole. The company supplied the polio vaccine to developing countries and that really helped in eradicating the polio virus. Now it is very close to being erected”,
The size of the polio project helped C.N.B.G prepare. For its work on COVID-19 and some of the global orientation of the new project is similarly similar : increasingly China seems to be looking towards the developing world. In China, there has never been a chance that the country will produce a coronavirus vaccine for the West, or that everything found in the West will be quickly available to Chinese. When I spoke with an epidemiologist in Shanghai back in May, he explained that tensions between the United States and China had lead to a sharp sense of self-reliance. “If you talk to general health care professionals in this country they don’t think that any vaccine in the US will be used here,” he said. “The first priority will be in the United States, and then they will prioritize ally US, then Africa and other places. China will be at the bottom of the list.”